e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Alpha-1 antitrypsin deficiency and the lung: celebrating the 50th anniversary of its first description
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New treatment strategies in AATD
A. Turner (Birmingham, United Kingdom)
Source:
Annual Congress 2013 –Alpha-1 antitrypsin deficiency and the lung: celebrating the 50th anniversary of its first description
Session:
Alpha-1 antitrypsin deficiency and the lung: celebrating the 50th anniversary of its first description
Session type:
Hot topics
Number:
155
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Turner (Birmingham, United Kingdom). New treatment strategies in AATD. Annual Congress 2013 –Alpha-1 antitrypsin deficiency and the lung: celebrating the 50th anniversary of its first description
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
New treatment approaches for IPF
Source: International Congress 2016 – ME2 New treatment approaches for idiopathic pulmonary fibrosis
Year: 2016
New perspectives in PGD prevention and treatment
Source: School Course 2012 - Lung Transplantation
Year: 2012
New therapeutic strategies in BOS
Source: Annual Congress 2007 - Bronchiolitis obliterans syndrome (BOS) after lung transplantation: new kids on the block
Year: 2007
New approaches for evaluation of treatment effectiveness among patients with pulmonary TB under DOTS implemented conditions
Source: Eur Respir J 2002; 20: Suppl. 38, 368s
Year: 2002
New methods of the treatment efficacy evaluation at asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 131s
Year: 2003
New methodologogic approaches to the management of antituberculous service
Source: Eur Respir J 2003; 22: Suppl. 45, 381s
Year: 2003
Physician perspectives: monitoring severe AATD and optimising treatment
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017
New perspectives in MDR-TB management
Source: International Congress 2016 – China Session II
Year: 2016
New guidelines to manage MDR-TB
Source: School Course 13
Year: 2013
New treatments in severe paediatric asthma
Source: International Congress 2017 – PG7 Paediatric asthma
Year: 2017
New frontiers in the management of asthma
Source: International Congress 2017 – State of the art session: "Paediatric"
Year: 2017
Challenges in TB treatment in adults
Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults
Year: 2014
Management of drug resistant pulmonary TB. New problems and perspectives
Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Year: 2009
New and future developments of therapy for asthma in children
Source: Eur Respir Mon 2012; 56: 224-234
Year: 2012
New approaches to MDR/XDR TB chemotherapy in children and adolescents
Source: International Congress 2019 – Tuberculosis: treatment and management
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept